Table 1 Baseline characteristics of patients with HCAP, HAP, or VAP
Baseline characteristic | HCAP | HAP | VAP | p value |
|---|---|---|---|---|
|  | (n = 199) | (n = 379) | (n = 606) |  |
Age, y, mean (SD) | 69.5 (13.4) | 63.3 (15.8) | 55.8 (19.8) | < 0.001 |
Male, n (%) | 117 (58.8) | 247 (65.2) | 411 (67.8) | 0.067 |
APACHE II, mean (SD) | 18.7 (6.4) | 16.1 (6.3) | 17.8 (5.7) | < 0.001 |
Race, n (%) | Â | Â | Â | < 0.001 |
 White | 151 (75.9) | 217 (57.3) | 429 (70.8) |  |
 Black | 25 (12.6) | 28 (7.4) | 72 (11.9) |  |
 Asian | 18 (9.1) | 97 (25.6) | 56 (9.2) |  |
 Other | 5 (2.5) | 37 (9.8) | 49 (8.1) |  |
Region, n (%) | Â | Â | Â | < 0.001 |
 United States | 174 (87.4) | 163 (43.0) | 376 (62.1) |  |
 Europe | 6 (3.0) | 51 (13.5) | 84 (13.9) |  |
 Latin America | 2 (1.0) | 43 (11.4) | 78 (12.9) |  |
 Asia | 14 (7.0) | 93 (24.5) | 49 (8.1) |  |
 Other | 3 (1.5) | 29 (7.7) | 19 (3.1) |  |
Comorbidities, n (%) | Â | Â | Â | Â |
Cardiac | 153 (76.9) | 198 (52.2) | 359 (59.2) | < 0.001 |
Pulmonary | 164 (82.4) | 186 (49.1) | 387 (63.9) | < 0.001 |
Renal/Urinary | 110 (55.3) | 127 (33.5) | 194 (32.0) | < 0.001 |
Diabetes | 98 (49.3) | 128 (33.8) | 198 (32.7) | < 0.001 |
Vascular | 74 (37.2) | 109 (28.8) | 187 (30.9) | 0.111 |
Neoplastic | 23 (11.6) | 68 (17.9) | 42 (6.9) | < 0.001 |
Hepatobiliary | 17 (8.5) | 42 (11.1) | 91 (15.0) | 0.031 |